Skip to main content
OpenTrials
Completed

NCT Number: NCT00852826

Evaluation of a Hemostatic and Sealing Agent to Prevent Surgical Complications After Axillary Lymphadenectomy

This study was intended to assess the value of a hemostatic and sealing agent, a collagen sponge coated with human coagulation factors (fibrinogen and thrombin) (TachoSil®), for decreasing occurrence of seroma after axillary lymphadenectomy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Hospital Universitario "Virgen de la Arrixaca"

Murcia, 30120, Spain

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with axillary lymphadenectomies performed for oncological conditions.

Exclusion criteria

  • Patients that did not want to participate in the study.

Treatment and study plan

Standard axillary lymphadenectomy

Procedure

Standard axillary lymphadenectomy

Collagen sponge coated with human coagulation factors

Procedure

Three patches of collagen sponge coated with human coagulation factors (TachoSil®, Nycomed Pharma, AS) were perpendicularly placed at the end of lymphadenectomy on the axillary neurovascular bundle, thoracodorsal pedicle, and costal wall, covering the axillary walls

Other names: TachoSil(R), Nycomed Pharma, AS.

Sponsors and collaborators

Lead sponsor

Hospital Universitario Virgen de la Arrixaca

Other

Registry information

Official study title

Value of a Hemostatic and Sealing Agent for Preventing Seroma After Axillary Lymphadenectomy

Important dates

Study start
2008
Study completion
2008
First posted
Feb 27, 2009
Registry last updated
Feb 27, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.